Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German health funds may reimburse PET (positron emission tomography):

This article was originally published in Clinica

Executive Summary

The social court in Leipzig, Germany, has ordered a regional division of the federal guilds' health insurance fund (IKK) to pay for the cost of a positron emission tomography (PET) procedure for a patient suffering from cancer. This is the first time that a statutory health insurance fund has been obliged to reimburse a PET examination, as it is normally considered a procedure for the private sector only. The court also wrote to the combined federal committee, which undertakes health technology assessment, and requested it to reassess it position on the reimbursement of PET and thereby close a loophole in the law.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel